GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Oxford Immunotec Global PLC (NAS:OXFD) » Definitions » Median PS Value

Oxford Immunotec Global (Oxford Immunotec Global) Median PS Value : $0.00 (As of May. 06, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Oxford Immunotec Global Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Oxford Immunotec Global's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $2.194. Oxford Immunotec Global's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.

As of today (2024-05-06), Oxford Immunotec Global's share price is $21.99. Oxford Immunotec Global's Median PS Value is $0.00. Therefore, Oxford Immunotec Global's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Oxford Immunotec Global's Median PS Value or its related term are showing as below:

OXFD's Price-to-Median-PS-Value is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.84
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Oxford Immunotec Global Median PS Value Historical Data

The historical data trend for Oxford Immunotec Global's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Immunotec Global Median PS Value Chart

Oxford Immunotec Global Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Median PS Value
Get a 7-Day Free Trial Premium Member Only - - - - -

Oxford Immunotec Global Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Oxford Immunotec Global's Median PS Value

For the Diagnostics & Research subindustry, Oxford Immunotec Global's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Immunotec Global's Price-to-Median-PS-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Oxford Immunotec Global's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Oxford Immunotec Global's Price-to-Median-PS-Value falls into.



Oxford Immunotec Global Median PS Value Calculation

Oxford Immunotec Global's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=2.194*0
=0.00

10-Year Median PS Ratio is 0.
Oxford Immunotec Global's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.194.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Immunotec Global  (NAS:OXFD) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Oxford Immunotec Global's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=21.99/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Immunotec Global Median PS Value Related Terms

Thank you for viewing the detailed overview of Oxford Immunotec Global's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Immunotec Global (Oxford Immunotec Global) Business Description

Traded in Other Exchanges
N/A
Address
143 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4SE
Oxford Immunotec Global PLC is a diagnostic company. It is focused on developing and commercializing proprietary tests for the management of underserved immune regulated conditions. Its products include T-spot TB, T-spot-CMV, T-spot PRT,T-cell extend etc. The company's research and development activities focus on Chronic infections, Transplantation, Autoimmune and Inflammatory disease, Immune oncology.
Executives
Andrew Scott Walton director 430 SOUTH SPRING STREET, BURLINGTON NC 27215
Mark R. Klausner director C/O OXFORD IMMUNOTEC GLOBAL 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Patricia Randall director C/O OXFORD IMMUNOTEC GLOBAL 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Richard A Sandberg director 330 NEVEDA STREET, NEWTON MA 02460-1458
Patrick J Balthrop director C/O MAXCYTE, INC., 9713 KEY WEST AVENUE, SUITE 400, ROCKVILLE MD 20850
Herm Rosenman director OXFORD IMMUNOTEC GLOBAL PLC, 94C INNOVATION DRIVE, HILTON PARK, SAN DIEGO X0 OX14 4RZ
James R Tobin director C/O CURIS INC, 4 MAGUIRE ROAD, LEXINGTON MA 02421
Ronald Asbury Andrews director 5791 VAN ALLEN WAY, CARLSBAD CA 92008
Peter Wrighton-smith director, officer: Chief Executive Officer C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON X0 OX14 4RZ
Mclaughlin Matthew T E officer: Chief Financial Officer C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Stefan C Linn officer: Chief Operating Officer C/O OXFORD IMMUNOTEC GLOBAL 940 INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Janet Louise Kidd officer: General Counsel C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Elizabeth M Keiley officer: SVP & General Counsel C/O ENTASIS THERAPEUTICS HOLDINGS INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451
Richard M. Altieri officer: Chief Financial Officer C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON X0 OX14 4RZ
Richard Wenstrup officer: Chief Medical Officer C/O OXFORD IMMUNOTEC GLOBAL, 94C INNOVATION DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE X0 OX14 4RZ

Oxford Immunotec Global (Oxford Immunotec Global) Headlines

From GuruFocus